US2016074445A1PendingUtilityA1
Compositions and methods for reducing blood alcohol content
Est. expiryAug 3, 2032(~6 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 7/00A61P 39/02A61K 33/30A61K 2035/11A61P 25/32A61P 3/00A61K 31/455A61K 31/4415A61K 31/355A61K 2300/00A61K 35/747A61K 31/7084A61K 31/122A61K 35/745A61K 9/0053A61K 31/714A61K 45/06
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are compositions and methods for reducing blood alcohol content following alcohol consumption. The inventive compositions and methods rapidly reduce blood alcohol content and alleviate symptoms of intoxication in a subject having an elevated blood alcohol content due to alcohol consumption.
Claims
exact text as granted — not AI-modified1 . A method of reducing blood alcohol content in a subject having an elevated blood alcohol content, the method comprising: providing an effective amount of Bifidobacterium to the subject, providing an effective amount of Lactobacillus to the subject, and providing an effective amount of NAD+ to the subject, wherein the subject's blood alcohol content is reduced.
2 . The method of claim 1 , further comprising providing zinc or vitamin B to the subject.
3 . The method of claim 1 , further comprising providing an antioxidant to the subject.
4 . The method of claim 3 , wherein the antioxidant is Coenzyme Q10 or vitamin E.
5 . The method of claim 1 , further comprising providing zinc, Coenzyme Q10, vitamin E, and vitamin B to the subject.
6 . The method of claim 1 , wherein 5-15 mg of NAD+ is provided to the subject.
7 . The method of claim 1 , wherein 25-100 billion cfu of Lactobacillus is provided to the subject.
8 . The method of claim 1 , wherein 25-100 billion cfu of Bifidobacterium is provided to the subject.
9 . The method of claim 1 , wherein the Lactobacillus comprises Lactobacillus GG, L. acidophilus DDS-1, L. casei, L. plantarum, L. salivarius, L. rhamnosus, or L. brevis.
10 . The method of claim 1 , wherein the Bifidobacterium comprises B. lactis, B. longum, B. infantis, or B. bifidum.
11 . The method of claim 1 , wherein the NAD+ is provided to the subject before the Lactobacillus and Bifidobacterium are provided to the subject.
12 . The method of claim 11 , wherein the NAD+ is provided to the subject 10-50 minutes before the Lactobacillus and Bifidobacterium are provided to the subject.
13 . The method of claim 1 , wherein the Lactobacillus, Bifidobacterium, and NAD+ are provided in a single composition.
14 . The method of claim 1 , wherein the Lactobacillus, Bifidobacterium, and NAD+ are provided in more than one composition.
15 . The method of claim 1 , wherein the Lactobacillus and Bifidobacterium are provided to the subject before the NAD+ is provided to the subject.
16 . The method of claim 15 , wherein the Lactobacillus and Bifidobacterium are provided to the subject 10-50 minutes before the NAD+ is provided to the subject.
17 . The method of claim 1 , wherein the subject's blood alcohol content is reduced by 10-50% within 10-40 minutes after providing NAD+, Lactobacillus, and Bifidobacterium to the subject.
18 . The method of claim 1 , wherein the Bifidobacterium, Lactobacillus, and NAD+ are administered orally.
19 . A composition comprising Lactobacillus, Bifidobacterium, NAD+, vitamin E, and vitamin B.
20 . The composition of claim 19 , wherein the composition further comprises zinc and Coenzyme Q10.Join the waitlist — get patent alerts
Track US2016074445A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.